Skip to main content

Table 3 Comparison of stimulant medication in Aboriginal and non-Aboriginal children by metropolitan and non-metropolitan areas

From: Use of prescription stimulant for Attention Deficit Hyperactivity Disorder in Aboriginal children and adolescents: a linked data cohort study

Parameter

Multivariate Analysis

Multivariate Analysisa

Metro

Non-Metro

HR (95 % CI)

P-Value

HR (95 % CI)

P-Value

Parents Aboriginal status

Non-Aboriginal parents

1.0

 

1.0

 

Both parents Aboriginal

0.35(0.25–0.49)

<0.001

0.28(0.20–0.38)

<0.001

Only father Aboriginal

0.96(0.73–1.26)

0.76

0.8(0.55–1.17)

0.26

Only mother Aboriginal

0.68(0.48–0.95)

0.03

0.66(0.44–1.0)

0.051

Mothers’ age group in years at birth

<20

1.51(1.28–1.78)

<0.001

1.56(1.24–1.97)

<0.001

20–24

1.48(1.33–1.66)

<0.001

1.30(1.10–1.53)

0.002

25–29

1.0

 

1.0

 

30–34

0.89(0.79–1.00)

0.04

0.85(0.71–1.01)

0.07

35–39

0.85(0.73–1.00)

0.57

1.06(0.82–1.35)

0.67

≥40

0.78(0.52–1.16)

0.22

1.00(0.55–1.82)

0.99

Sex

Female

1.0

 

1.0

 

Male

3.69(3.33–4.09)

<0.001

4.24(3.61–4.99)

<0.001

Socioeconomic disadvantage

Least disadvantaged

1.0

 

1.0

 

Less disadvantaged

1.19(1.07–1.33)

<0.001

1.15(0.98–1.35)

0.10

Little disadvantaged

1.33(1.16–1.53)

<0.001

1.28(1.04–1.58)

0.02

More disadvantaged

1.4(1.16–1.69)

<0.001

1.13(0.85–1.49)

0.41

Most disadvantaged

2.17(1.89–2.49)

<0.001

1.80(1.49–2.17)

<0.001

  1. aAll parameters were included in the regression model so as to adjust each result for potential confounding by all other covariates